Paradigm Health: $78 Million Series B Raised To Expand Global Clinical Trial Infrastructure
By Amit Chowdhry ● Dec 8, 2025
Paradigm Health has raised $78 million in an oversubscribed Series B financing round led by ARCH Venture Partners, marking one of the company’s most significant capital infusions as it accelerates efforts to make clinical trials part of routine care across the United States and globally. The round included participation from new investor DFJ Growth, along with existing backers F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital, and the American Cancer Society’s BrightEdge Fund, several of which increased their commitments through super pro rata positions.